Orthofix Reports Clinical Trial Results of Trinity Elite Cellular Bone Allograft in Lumbar Fusion Procedures
Shots:
- The 12mos. results from the clinical study evaluating the efficacy & safety of Trinity Elite CBA in 274 patients undergoing lumbar spinal fusion at 9 clinical sites across the US
- The results showed that patients treated with Trinity Elite CBA achieved fusion rates of 98.6% as measured by bridging bone @12mos. follow-up using thin-cut CT scans. Oswestry disability index (ODI) and visual analogue scale (VAS) for back and leg pain were used as clinical outcome measures
- The results were published in Neurology International. Trinity Elite was safe & efficacious alternative to autograft for patients undergoing lumbar fusion procedures and demonstrate the compelling benefits of the cellular bone allograft
Ref: Bussinesswire | Image: Orthofix
Related News:- Orthofix Medical Signs a License Agreement with LimaCorporate to Provide Novel Solution for High Hip Dislocation in the US
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
